Pancreatic Cancer Canada

508 - 36 Eglinton Ave. W
Toronto, ON M4R 1A1
Executive Director: Michelle Capobianco
Board Chair: Dr. Michael Clarfield

Charitable Reg. #: 84870 1967 RR0001
Sector: Health - Cancer
Public Foundation

Results Reporting

Grade: B-

The grade is based on the charity's public reporting of the work it does and the results it achieves.

Financial Transparency

Audited financial statements for current and previous years available on the charity's website [Audited financial statement for most recent year]

Need for Funding

Funding Reserves Program Costs

Spending Breakdown

Cents to the Cause

2014 2015 2016
For a dollar donated, cents funding the cause after fundraising and admin costs, excluding surplus.

Full-time staff #5

Avg. Compensation $48,572

Top 10 Staff Salary Range

$350k + 0
$300k - $350k 0
$250k - $300k 0
$200k - $250k 0
$160k - $200k 0
$120k - $160k 0
$80k - $120k 1
$40k - $80k 4
< $40k 0
Information from most recent CRA Charities Directorate filings for F2016

About Pancreatic Cancer Canada:

Pancreatic Cancer Canada Foundation (PCC) is Canada’s only foundation dedicated to raising money and awareness for pancreatic cancer. Its goals are to improve overall patient survival rates and create a brighter future for those affected. To achieve this, it has invested over $3.5m into research and has run awareness and support programs.

Pancreatic cancer is the fourth leading cause of cancer death in Canada among men and women. Of the major cancers, pancreatic cancer is the only one with single digit survival rates, with the 5-year survival rate at 8%. There has been little advancement in the fight, with this figure having not improved in the last 40 years. It remains one of the most seriously underfunded cancers. Pancreatic cancer was featured as the Special Topic in the 2017 edition of the Canadian Cancer Society’s Canadian Cancer Statistics publication.

In F2016, Pancreatic Cancer Canada disbursed $312k to the Princess Margaret Cancer Centre, $225k to the innovative grant competition and contributed $50k in a collaboration with the Canadian Cancer Society and Craig’s Cause Collaboration. Its current research focus is a project called PancOne™, a multi-disciplinary partnership between major cancer centres in Canada with the aim to evaluate metastatic pancreatic cancer molecular signatures in a clinical trial setting.

Financial Review:

Pancreatic Cancer Canada is a medium-cap charity with donations and special events revenues of $1.5m in F2016. PCC’s administrative costs were 11% of revenues, while fundraising costs were 31% of donations. For every dollar donated, 58 cents goes towards the cause, falling outside of Ci’s reasonable range. It had funding reserves of $1.7m, which cover program costs for 1.2 years.

This charity report is an update that is being reviewed by PCC. Changes and edits may be forthcoming.

Updated July 20, 2017 by Josh Lam and Nov. 1, 2017 by Greg Thomson.

Financial Ratios

Fiscal year ending December
Administrative costs as % of revenues 11.5%33.3%23.2%
Fundraising costs as % of donations 30.8%12.3%14.8%
Program cost coverage (%) 120.0%993.4%182.7%

Summary Financial Statements

All figures in $s
Donations 1,218,753971,3771,046,686
Government funding 08,5200
Special events 235,709162,543191,164
Investment income 8,8587,5356,758
Total revenues 1,463,3201,149,9751,244,608
Program costs 121,82000
Grants 1,282,437157,000551,600
Administrative costs 167,059380,192286,963
Fundraising costs 447,627139,510183,335
Cash flow from operations (555,623)473,273222,710
Funding reserves 1,685,3401,559,5921,007,509
Note: In F2016, PCC restated its expenses in a Notice to Reader to better reflect its expenses by activity. These numbers are not comparable to the F2015 and F2014 reported data.

Comments added by the Charity:

No comments have been added by charity
Go to top